Pay in 4 interest-free payments of $5.04 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
This dual-action profile makes BPC-157 a unique and compelling agent in the field of peptide therapy
Elevated Dose: 4.8 mg total contains 3 mg GHK-Cu and 600 mcg each of BPC-157, TB-4, and KPV
Key Research Characteristics: Selective NNMT inhibition, supporting studies into NAD metabolism and methylation pathways Investigated in the context of obesity, metabolic dysfunction, and lipid accumulation models Cell-permeable small molecule with favourable in vitro profile Studied for potential effects on adipocyte differentiation and energy expenditure Specifications: Form: Lyophilised powder For research purposes only
Ur service is awesome
By Simar Bajaj Genetic prediction models are poised to revolutionize medicine
US$ 25.82
US$ 24.60
US$ 20.67
